155 related articles for article (PubMed ID: 36418715)
1. The Interaction Between SMAD1 and YAP1 Is Correlated with Increased Resistance of Gastric Cancer Cells to Cisplatin.
Chen W; Hu J; He Y; Yu L; Liu Y; Cheng Y; Jia B; Li X; Yu G; Wang Y
Appl Biochem Biotechnol; 2023 Oct; 195(10):6050-6067. PubMed ID: 36418715
[TBL] [Abstract][Full Text] [Related]
2. Exosome-Derived Circ-PVT1 Contributes to Cisplatin Resistance by Regulating Autophagy, Invasion, and Apoptosis Via miR-30a-5p/YAP1 Axis in Gastric Cancer Cells.
Yao W; Guo P; Mu Q; Wang Y
Cancer Biother Radiopharm; 2021 May; 36(4):347-359. PubMed ID: 32799541
[No Abstract] [Full Text] [Related]
3. Increase in Cisplatin Resistance by MeCP2 in Human Gastric Cancer through the Activation of the AKT Pathway by Facilitating PDK-1 Transcription.
Guo B; Cai S; Li W; Guo C; Liu Y; Ma X; Ma H; Zhao L
Curr Cancer Drug Targets; 2022; 22(5):414-425. PubMed ID: 35209822
[TBL] [Abstract][Full Text] [Related]
4. MiR-874-3p represses the migration and invasion yet promotes the apoptosis and cisplatin sensitivity via being sponged by long intergenic non-coding RNA 00922 (LINC00922) and targeting Glycerophosphodiester Phosphodiesterase Domain Containing 5 (GDPD5) in gastric cancer cells.
Zhang X; Dai X; Zhao X; Wang J; Dou J; Zhuang H; Chen N; Zhao H
Bioengineered; 2022 Mar; 13(3):7082-7104. PubMed ID: 35282764
[TBL] [Abstract][Full Text] [Related]
5. Targeted Regulation of FoxO3a by miR-372 to Mediate Gastric Carcinoma Cell Apoptosis and DDP Drug Resistance.
Wang C; Wang C; Qiu C; Su Z
Cancer Biother Radiopharm; 2020 Dec; 35(10):753-759. PubMed ID: 32379491
[No Abstract] [Full Text] [Related]
6. circ-LDLRAD3 Knockdown Reduces Cisplatin Chemoresistance and Inhibits the Development of Gastric Cancer with Cisplatin Resistance through miR-588 Enrichment-Mediated SOX5 Inhibition.
Liang Q; Chu F; Zhang L; Jiang Y; Li L; Wu H
Gut Liver; 2023 May; 17(3):389-403. PubMed ID: 35975639
[TBL] [Abstract][Full Text] [Related]
7. Circular RNA circ_ASAP2 regulates drug sensitivity and functional behaviors of cisplatin-resistant gastric cancer cells by the miR-330-3p/NT5E axis.
Sun Y; Ma J; Lin J; Sun D; Song P; Shi L; Li H; Wang R; Wang Z; Liu S
Anticancer Drugs; 2021 Oct; 32(9):950-961. PubMed ID: 34016832
[TBL] [Abstract][Full Text] [Related]
8. Linc00852 from cisplatin-resistant gastric cancer cell-derived exosomes regulates COMMD7 to promote cisplatin resistance of recipient cells through microRNA-514a-5p.
Cao S; Fu B; Cai J; Zhang D; Wang C; Wu H
Cell Biol Toxicol; 2023 Apr; 39(2):483-496. PubMed ID: 35088190
[TBL] [Abstract][Full Text] [Related]
9. Deubiquitinase PSMD7 promotes the proliferation, invasion, and cisplatin resistance of gastric cancer cells by stabilizing RAD23B.
Wang J; Liu R; Mo H; Xiao X; Xu Q; Zhao W
Int J Biol Sci; 2021; 17(13):3331-3342. PubMed ID: 34512150
[TBL] [Abstract][Full Text] [Related]
10. HCP5 contributes to cisplatin resistance in gastric cancer through miR-128/HMGA2 axis.
Liang L; Kang H; Jia J
Cell Cycle; 2021 Jun; 20(11):1080-1090. PubMed ID: 33993846
[TBL] [Abstract][Full Text] [Related]
11. Cisplatin resistance and malignant behaviors of lung cancer cells are promoted by circ_0002360 via targeting miR-6751-3p to regulate the expression of ZNF300.
Ding L; Li L; Tang Z
Thorac Cancer; 2022 Apr; 13(7):986-996. PubMed ID: 35166026
[TBL] [Abstract][Full Text] [Related]
12. Upregulation of Long Noncoding RNA (lncRNA) X-Inactive Specific Transcript (XIST) is Associated with Cisplatin Resistance in Non-Small Cell Lung Cancer (NSCLC) by Downregulating MicroRNA-144-3p.
Tian LJ; Wu YP; Wang D; Zhou ZH; Xue SB; Zhang DY; Wei YG; Liu W
Med Sci Monit; 2019 Oct; 25():8095-8104. PubMed ID: 31659146
[TBL] [Abstract][Full Text] [Related]
13. LAMA4 activated by Androgen receptor induces the cisplatin resistance in gastric cancer.
Peng L; Li Y; Wei S; Li X; Dang Y; Zhang W; Zhang G
Biomed Pharmacother; 2020 Apr; 124():109667. PubMed ID: 31958762
[TBL] [Abstract][Full Text] [Related]
14. Low SP1 SUMOylation-dependent SNHG17 upregulation promotes drug resistance of gastric cancer through impairing hsa-miR-23b-3p-induced Notch2 inhibition.
Huang G; Cai G; Hu D; Li J; Xu Q; Chen Z; Xu B
Cell Oncol (Dordr); 2022 Dec; 45(6):1329-1346. PubMed ID: 36214997
[TBL] [Abstract][Full Text] [Related]
15. Knockdown of long non-coding RNA HOTAIR inhibits cisplatin resistance of gastric cancer cells through inhibiting the PI3K/Akt and Wnt/β-catenin signaling pathways by up-regulating miR-34a.
Cheng C; Qin Y; Zhi Q; Wang J; Qin C
Int J Biol Macromol; 2018 Feb; 107(Pt B):2620-2629. PubMed ID: 29080815
[TBL] [Abstract][Full Text] [Related]
16. PCAT-1 contributes to cisplatin resistance in gastric cancer through miR-128/ZEB1 axis.
Guo Y; Yue P; Wang Y; Chen G; Li Y
Biomed Pharmacother; 2019 Oct; 118():109255. PubMed ID: 31352238
[TBL] [Abstract][Full Text] [Related]
17. Downregulation of Linc00173 increases BCL2 mRNA stability via the miR-1275/PROCA1/ZFP36L2 axis and induces acquired cisplatin resistance of lung adenocarcinoma.
Tao X; Li Y; Fan S; Wu L; Xin J; Su Y; Xian X; Huang Y; Huang R; Fang W; Liu Z
J Exp Clin Cancer Res; 2023 Jan; 42(1):12. PubMed ID: 36627670
[TBL] [Abstract][Full Text] [Related]
18. Long Noncoding RNA Plasmacytoma Variant Translocation 1 Regulates Cisplatin Resistance via miR-3619-5p/TBL1XR1 Axis in Gastric Cancer.
Wu C; Hu Y; Ning Y; Zhao A; Zhang G; Yan L
Cancer Biother Radiopharm; 2020 Dec; 35(10):741-752. PubMed ID: 32407172
[No Abstract] [Full Text] [Related]
19. Inhibition of MGMT-mediated autophagy suppression decreases cisplatin chemosensitivity in gastric cancer.
Lei Y; Tang L; Hu J; Wang S; Liu Y; Yang M; Zhang J; Tang B
Biomed Pharmacother; 2020 May; 125():109896. PubMed ID: 32007918
[TBL] [Abstract][Full Text] [Related]
20. YAP1 enhances cell proliferation, migration, and invasion of gastric cancer in vitro and in vivo.
Sun D; Li X; He Y; Li W; Wang Y; Wang H; Jiang S; Xin Y
Oncotarget; 2016 Dec; 7(49):81062-81076. PubMed ID: 27835600
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]